
Sign up to save your podcasts
Or


In contrast to traditional monoclonal antibodies or small molecules, hyperbaric oxygen therapy involves a different type of treatment. But is this therapeutic option effective for our ulcerative colitis patients? To better understand this, Dr. Neil Nandi speaks with Dr. Parambir Dulai from Northwestern University to share his research on hyperbaric oxygen therapy.
By ReachMD4.7
1818 ratings
In contrast to traditional monoclonal antibodies or small molecules, hyperbaric oxygen therapy involves a different type of treatment. But is this therapeutic option effective for our ulcerative colitis patients? To better understand this, Dr. Neil Nandi speaks with Dr. Parambir Dulai from Northwestern University to share his research on hyperbaric oxygen therapy.

137 Listeners

68 Listeners

1 Listeners

3 Listeners

3 Listeners

0 Listeners

6 Listeners

15 Listeners

0 Listeners

3,353 Listeners